Torren Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37K Buy
32
+25
+357% +$29.5K 0.02% 86
2026
Q2
$8.4K Hold
7
– – ﹤0.01% 233
2026
Q1
$6.44K Sell
7
-208
-97% -$211K ﹤0.01% 269
2025
Q4
$231K Buy
+215
New +$206K 0.12% 58

Other funds holding LLY

Torren Management's LLY Position: Q3 2026 in Review

Torren Management increased its Eli Lilly (LLY) stake by 357% in Q3 2026, buying an estimated $29.5K and bringing the position to 32 shares worth $37K. The position accounts for 0.02% of the portfolio, ranked #86.

Torren Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $231K in Q4 2025. 2,825 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Torren Management held 32 shares of Eli Lilly worth $37K as of Q3 2026.
  • Torren Management bought 25 Eli Lilly shares in Q3 2026, an estimated $29.5K.
  • Eli Lilly made up 0.02% of Torren Management's portfolio in Q3 2026, its #86 holding.
  • Torren Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's Eli Lilly position peaked at $231K in Q4 2025.
  • 2,825 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.